CHIOSTRI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 4251
EU - Europa 4049
AS - Asia 211
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8516
Nazione #
US - Stati Uniti d'America 4246
PL - Polonia 2816
IE - Irlanda 388
SE - Svezia 357
IT - Italia 221
DE - Germania 84
FI - Finlandia 84
CN - Cina 73
TR - Turchia 56
VN - Vietnam 43
GB - Regno Unito 40
JO - Giordania 31
UA - Ucraina 23
BE - Belgio 16
BG - Bulgaria 5
CA - Canada 5
ES - Italia 4
IN - India 4
NL - Olanda 3
RO - Romania 3
AT - Austria 2
CM - Camerun 2
EU - Europa 2
RU - Federazione Russa 2
FR - Francia 1
IR - Iran 1
MM - Myanmar 1
MY - Malesia 1
SC - Seychelles 1
SG - Singapore 1
Totale 8516
Città #
Warsaw 2816
Fairfield 838
Woodbridge 405
Dublin 388
Chandler 361
Seattle 350
Ashburn 328
Cambridge 319
Houston 300
Wilmington 241
Ann Arbor 135
Altamura 122
Lawrence 122
Princeton 96
Jacksonville 65
Beijing 59
Boardman 59
Medford 59
Florence 57
Buffalo 55
Izmir 54
San Diego 51
Boston 50
Dong Ket 39
Norwalk 27
Phoenix 21
Brussels 16
Guangzhou 12
Andover 11
London 8
Falls Church 7
Sofia 5
Barcelona 4
Laurel 4
Rome 4
Toronto 4
Chiusi 3
Delhi 3
Redwood City 3
Timisoara 3
Bremen 2
Elice 2
Empoli 2
Fuzhou 2
Milan 2
Montevarchi 2
Old Bridge 2
Siena 2
Anghiari 1
Anzio 1
Arnsberg 1
Auburn Hills 1
Bologna 1
Carbonia 1
Centro 1
Cincinnati 1
Council Bluffs 1
Evanston 1
Frosinone 1
Grevenbroich 1
Hanover 1
Islington 1
Kuala Lumpur 1
Montréal 1
Naaldwijk 1
Negrar 1
Norderstedt 1
Nürnberg 1
Prato 1
Saint Petersburg 1
San Mateo 1
Utrecht 1
Yangon 1
Totale 7545
Nome #
Acute glucose dysmetabolism in the elderly with ST elevation myocardial infarction submitted to mechanical revascularization 211
Acute hyperglycemia and insulin resistance in acute heart failure syndromes without previously known diabetes 209
Early invasive strategy and outcomes of non-ST-elevation acute coronary syndrome patients: is time really the major determinant? 207
Prevalence, predictors and prognostic significance of microalbuminuria in acute cardiac patients: a single center experience 206
Intraaortic Balloon Pump: Incidence and Predictors of Complications in the Florence Registry 206
Correlates of acute insulin resistance in the early phase of non-diabetic ST-elevation myocardial infarction 205
In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes 205
Uric acid in the early risk stratification of ST-elevation myocardial infarction 202
Continuous renal replacement therapy: should the cardiologist be able to manage it out of intensive care units? 198
Prior and new onset anemia in ST-elevation myocardial infarction: a different prognostic role? 198
ST-elevation myocardial infarction with preserved ejection fraction: The impact of worsening renal failure 194
Intra-aortic balloon pump in intensive cardiac care: a registry in Florence 193
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 193
The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia 192
Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes 189
Persistent and selective upregulation of renin-angiotensin system in circulating T lymphocytes in unstable angina. 188
Glycated hemoglobin in ST-elevation myocardial infarction without previously known diabetes: Its short and long term prognostic role 187
The prognostic impact of glycated hemoglobin in diabetic ST-elevation myocardial infarction 186
STEMI patients--the more you bleed, the more you die: a comparison between classifications 186
The impact of hypertension on patients with acute coronary syndromes 183
Lactate in the acute phase of ST-elevation myocardial infarction treated with mechanical revascularization A single-center experience 178
T lymphocyte based renin angiotensin system in obesity 137
Clinical and scintigraphic follow-up of ST-elevation myocardial infarction patients submitted to primary angioplasty and randomized to thrombus aspiration with Angiojet® or Export® 100
COmparison between COronary THrombus aspiration with Angiojet® or Export® catheter in patients with ST-elevation myocardial infarction submitted to primary angioplasty: The COCOTH Study 97
Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. 95
Effects of smoking in patients treated with cardiac resynchronization therapy 88
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 86
Cardiac efficiency improvement after slow continuous ultrafiltration is assessed by beat-to-beat minimally invasive monitoring in congestive heart failure patients: a preliminary report 83
Cardiovascular effects of mild hypothermia in post-cardiac arrest patients by beat-to-beat monitoring. A single centre pilot study. 83
Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response 81
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? 81
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 81
Dual antiplatelet therapy tailored on platelet function test after coronary stent implantation: a real-world experience 80
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. 78
Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients. 75
Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience 73
Levosimendan produces an additional clinical and hemodynamic benefit in patients with decompensated heart failure successfully submitted to a fluid removal treatment 73
Impact of Hypertension History on Short and Long-Term Prognosis in Patients with Acute Myocardial Infarction Treated with Percutaneous Angioplasty: Comparison Between STEMI and NSTEMI. 72
Microalbuminuria in Non-Diabetic Stemi : An Independent Predictor for Acute Kidney Injury 70
A new post-PCI scoring system for in-hospital mortality in STEMI patients 69
Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study 69
Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction 68
Usefulness of Hyponatremia in the Acute Phase of ST-Elevation Myocardial Infarction as a Marker of Severity. 68
Exaggerated myocardial oxLDL amount and LOX-1 receptor over-expression associated with coronary microvessel inflammation in unstable angina 68
Hemodynamic effects in patients with atrial fibrillation submitted to electrical cardioversion. 68
Prognostic role of glucose abnormalities in patients with ST-elevation myocardial infarction and mild renal impairment. 68
Nonthyroidal illness syndrome in ST-elevation myocardial infarction treated with mechanical revascularization. 67
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 67
Acute Insulin Resistance Assessed by the Homeostatic Model Assessment in Acute Coronary Syndromes Without Previously Known Diabetes. 66
NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers 66
Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients 66
Congestive heart failure and decongestion ability of two different treatments: continuous renal replacement and diuretic therapy: experience of a cardiac step down unit. 65
Evaluation of acid-base balance in ST-elevation myocardial infarction in the early phase: a prognostic tool? 65
The prognostic role of chronic obstructive pulmonary disease in ST-elevation myocardial infarction after primary angioplasty 65
Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis 64
Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. 63
Clinical and prognostic significance of increased liver enzymes in ST-elevation myocardial infarction 63
A metabolic approach during normothermic regional perfusion in uncontrolled donors after circulatory death—A pilot study 63
Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: A pilot study. 62
BLEEDING EVENTS IN REFRACTORY CARDIAC ARREST TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION - A single centre experience. 62
Procalcitonin as a Reliable Biomarker in Acute Coronary Syndromes: What Is Its Role? 61
Comparison between drug-eluting and bare metal stent on ST-elevation myocardial infarction outcome: should second-generation drug-eluting stent be preferred? 61
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 61
Endotoxin role in cardiogenic shock: A brief report. 60
Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures. 59
Mechanical ventilation in the early phase of ST elevation myocardial infarction treated with mechanical revascularization. 59
Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers. 59
Dynamic behaviour of lactate values during mild hypothermia in patients with cardiac arrest. 56
Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. 56
Time of onset and outcome of cardiogenic shock in acute coronary syndromes. 55
The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. 54
Impact of age on the prognostic value of body mass index in ST-Elevation myocardial infarction. 53
Procalcitonin in acute cardiac patients 52
Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data 52
Cardiac cycle efficiency and dicrotic pressure variations: New parameters for fluid therapy: An observational study 51
Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. 50
Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: a single-centre 6-year registry 49
The influence of renal function on the prognostic value of Nt-pro brain natriuretic peptide in St-elevation myocardial infarction. 49
Dynamic behavior of lactate values in venous-arterial extracorporeal membrane oxygenation for refractory cardiac arrest. 45
Continuous recording of dicrotic and pulse pressures during head-up tilting test: the vasodepressive profile. Preliminary data. 44
Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study 44
Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement 43
Predictors for in-hospital peak glycemia in STEMI patients without previously known diabetes 42
Comorbidities in stemi patients submitted to primary PCI: Temporal trends and impact on mortality: A 6-year single center experience. 38
Age as a Prognostic Factor in Patients with Acute Coronary Syndrome undergoing Urgent/Emergency Cardiac Surgery 38
SYSTEMIC ARTERIAL WAVEFORM ANALYSIS AND ASSESSMENT OF BLOOD FLOW RUDING EXTRACORPOREAL CIRCULATION 35
Baroreflex function in vasodepressive syncope: detection of early impairment.Med Sci Monit. 2003 Mar;9(3):CR125-30. 35
Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. 28
The impact of blood transfusion on short and long term prognosis in STEMI patients treated with primary percutaneous coronary intervention: A single center-experience. 24
Malapposed Struts with Cre8, Biomatrix, and Xience Stents Assessed with OCT Immediately after Implantation and at 6-Month Follow-Up: Can the Different Biomechanical Characteristics of the Three Stents Impact on Struts Malapposition? 23
RENAL REPLACMENT THERAPY IN PATIENTS WITH REFRACTORY CARDIAC ARREST UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION. 22
Predictors of early mortality in acute cardiac patients requiring renal replacement therapy: a single center experience. 21
Thrombus aspiration in elderly STEMI patients: A single center experience. 21
T Cell-Based RAS Activity and Insulin Levels in Obese Subjects with Low Grade Inflammation 11
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure 10
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 5
Rotational mechanics of the left ventricle in AL amyloidosis 2
Totale 8559
Categoria #
all - tutte 13754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201884 0000 00 00 00084
2018/20191508 45488650 12845 7345 86183411308
2019/20202271 18220070170 286256 237270 22814818539
2020/20211328 14014845140 66158 6791 1341857579
2021/2022682 24497923 2831 2752 3334113189
2022/20231659 16531059106 136295 26690 15617563
Totale 8559